Oct 31
|
Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns
|
Oct 31
|
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
|
Oct 31
|
Teva Statement on European Commission Decision; Company to Appeal
|
Oct 11
|
Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes
|
Oct 11
|
Update: Teva Pharmaceutical to Pay $450 Million to Settle Anti-Kickback Allegations
|
Oct 10
|
Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations
|
Oct 9
|
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ...
|
Oct 8
|
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
|
Jul 29
|
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
|
Jul 29
|
Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
|
Jul 25
|
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
|
Jun 24
|
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
|
Jun 24
|
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
|
Jun 22
|
Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a Positive Rating from Analysts?
|
May 21
|
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
|
May 17
|
Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
|
Apr 6
|
New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024
|
Apr 4
|
Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
|
Apr 3
|
3 No-Brainer Stocks to Buy With $600 Right Now
|
Apr 3
|
Biden and Senator Sanders to highlight efforts lower cost of asthma inhalers
|